Abstract

Deep vein thrombosis (DVT) is an important cause of short-term mortality and long-term morbidity. Although acute DVT is often well managed, there is uncertainty in the management of chronic DVT which is increasingly being noted among patients presenting with similar symptoms to their initial DVT. The presence of a residual venous clot can be a problem for both physicians and patients fearing the risk of emboli to the same extent as the acute DVT. There are also issues in the accurate diagnosis and appropriate management of chronic DVT, which is the focus of the second part of this review.

[download-attachments container="div" style="list" display_icon="1" display_count="1" display__size="0"]

References

1. Stephenson EP, Liem TK. Duplex imaging of residual venous obstruction to guide duration of therapy for lower extremity deep venous thrombosis. J Vasc Surg Venous Lymphat Disord [Internet]. 2015;3(3):326–32.
2. Prandoni P. Residual Clot in Patients with Deep Vein Thrombosis and Pulmonary Embolism: Prognostic Implications. J Hematol Thromb [Internet]. 2015;1(1):1–3.
3. Denny N, Musale S, Edlin H, Serracino-Inglott F, Thachil J. Iliofemoral deep vein thrombosis and the problem of post thrombotic syndrome. Acute Med. 2018;17(2):99-103
4. Prandoni P, Lensing AW, Prins MH, Bernardi E, Marchiori A, Bagatella P, et al. Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism. Ann Intern Med.2002;137(12):955–60.
5. Emelianov SY, Chen X, O’Donnell M, Knipp B, Myers D, Wakefield TW, et al. Triplex ultrasound: Elasticity imaging to age deep venous thrombosis. Ultrasound Med Biol. 2002;28(6):757–67.
6. Kahn SR. How I treat postthrombotic syndrome. Blood. 2009;114(21):4624–31.
7. Aguilar C, Del Villar V. Combined D-dimer and clinical probability are useful for exclusion of recurrent deep venous thrombosis. Am J Hematol. 2007;82(1):41–4.
8. Rathbun SW, Whitsett TL, Vesely SK, Raskob GE. Clinical utility of d-dimer in patients with suspected pulmonary embolism and nondiagnostic lung scans or negative CT findings. Chest. 2004;125(3):851–5.
9. Kyrle PA. How I Treat How I treat recurrent deep-vein thrombosis. Blood. 2017;127(6):696–703.
10. Le Gal G, Kovacs MJ, Carrier M, Do K, Kahn SR, Wells PS, et al. Validation of a diagnostic approach to exclude recurrent venous thromboembolism. J Thromb Haemost. 2009;7(5):752–9.
11. Bates SM, Jaeschke R, Stevens SM, Goodacre S, Wells PS, Stevenson MD, et al. Diagnosis of DVT: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Vol. 141, Chest. 2012.
12. Thachil J. Providing accurate information to patients who develop deep vein thrombosis. Clin Med. 2013;13(5):449–51.
13. Tan M, Mos ICM, Klok FA, Huisman M V. Residual venous thrombosis as predictive factor for recurrent venous thromboembolim in patients with proximal deep vein thrombosis: A sytematic review. Vol. 153, British Journal of Haematology. 2011. p. 168–78.
14. Agnelli G, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M, et al. Apixaban for Extended Treatment of Venous Thromboembolism. N Engl J Med [Internet]. 2013;368(8):699–708.
15. Weitz JI, Lensing AWA, Prins MH, Bauersachs R, BeyerWestendorf J, et al. Rivaroxaban or Aspirin for Extended Treatment of Venous thromboembolism. N Engl J Med. 2017 Mar 30;376(13):1211-1222